RXRX - RECURSION PHARMACEUTICALS, INC.
3.64
0.100 2.747%
Share volume: 16,101,964
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$3.54
0.10
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-06-2024 | 02-28-2025 | 05-05-2025 | 11-05-2025 | 02-25-2026 | |
| Cash flow financing | 13.897 M | 263.122 M | 16.462 M | 10.639 M | 40.527 M | 251.340 M | 132.006 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -102.300 M | 176.721 M | -47.325 M | 170.665 M | -98.700 M | 131.431 M | 84.689 M | |
| Net income | -91.373 M | -97.540 M | -95.842 M | -178.906 M | -202.487 M | -162.253 M | -108.122 M | |
| Depreciation | 7.377 M | 8.968 M | 7.198 M | 12.951 M | 19.331 M | 21.043 M | 19.478 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 2.599 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.653 M | -4.182 M | -4.562 M | 275.456 M | -7.270 M | -2.549 M | -1.244 M | |
| Net Borrowings | -286.847 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -6.653 M | 1.182 M | 4.562 M | 1.298 M | 1.832 M | 243.000 K | 1.244 M | |
| Cash Change | 296.326 M | 176.603 M | -46.922 M | 167.193 M | -93.867 M | 133.300 M | 86.776 M |